These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35689083)

  • 21. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis.
    Wei Y; Hay JW; Hay AR; Suen SC
    BMC Urol; 2022 May; 22(1):76. PubMed ID: 35550071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction.
    Noble SM; Ahern AM; Worthington J; Hashim H; Taylor H; Young GJ; Brookes S; Abrams P; Johnson L; Khan R; Page T; Swami KS; Lane JA
    BJU Int; 2020 Nov; 126(5):595-603. PubMed ID: 32558178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.
    Ohsfeldt RL; Kreder KJ; Klein RW; Chrischilles EA
    J Manag Care Pharm; 2004; 10(5):412-22. PubMed ID: 15369424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy.
    Rojanasarot S; Cutone B; Durand K; Zorn KC; Chughtai B; Bhojani N; Elterman DS
    J Endourol; 2023 May; 37(5):575-580. PubMed ID: 36762936
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II--results.
    Blute M; Ackerman SJ; Rein AL; Beusterien K; Sullivan EM; Tanio CP; Strauss MJ; Manyak MJ
    Urology; 2000 Dec; 56(6):981-7. PubMed ID: 11113744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP).
    Magistro G; Stief CG; Gratzke C
    Curr Urol Rep; 2017 Aug; 18(10):82. PubMed ID: 28852996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Ulchaker JC; Martinson MS
    Clinicoecon Outcomes Res; 2018; 10():29-43. PubMed ID: 29343977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement.
    Lourenco T; Armstrong N; N'Dow J; Nabi G; Deverill M; Pickard R; Vale L; MacLennan G; Fraser C; McClinton S; Wong S; Coutts A; Mowatt G; Grant A
    Health Technol Assess; 2008 Nov; 12(35):iii, ix-x, 1-146, 169-515. PubMed ID: 19032882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review.
    Tzeng M; Basourakos SP; Lewicki PJ; Hu JC; Lee RK
    Eur Urol Focus; 2022 Mar; 8(2):522-531. PubMed ID: 33663982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
    Eure G; Rukstalis D; Roehrborn C
    J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
    [No Abstract]   [Full Text] [Related]  

  • 32. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.
    Wu X; Zhou A; Heller M; Kohlbrenner R
    J Vasc Interv Radiol; 2022 Dec; 33(12):1605-1615. PubMed ID: 35964881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of prostatic urethral lift vs prostatic artery embolization for benign prostatic hyperplasia: a systematic review and network meta-analysis.
    Lucas-Cava V; Sánchez-Margallo FM; Insausti-Gorbea I; Sun F
    BJU Int; 2023 Feb; 131(2):139-152. PubMed ID: 35417622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for pharmacotherapy for storage symptoms after transurethral resection of the prostate in patients with benign prostatic hyperplasia.
    Tsai CH; Fan YH; Lin ATL; Huang WJ
    Low Urin Tract Symptoms; 2022 Sep; 14(5):329-333. PubMed ID: 35313391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
    BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.